---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-044842"
form_type: "8-K"
ticker: "JAGX"
cik: "0001585608"
company_name: "Jaguar Health, Inc."
filed_at: "2025-03-26T23:59:59+00:00"
generated_at: "2026-05-24T04:57:53.397285+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Jaguar Health raises $3.45M via convertible notes; CEO & insiders participate

## Summary
- $3.448M aggregate principal convertible notes at 6% interest, 3-month maturity, convertible into common stock at ~$5.54/share.
- Insiders (CEO Conte, CFO, board members) purchase $535K of notes, also receive warrants at $5.43 exercise price.
- Warrants exercisable immediately, expire in 5 years; up to 622,598 warrant shares plus 622,598 conversion shares.
- Proceeds for working capital; H.C. Wainwright placement agent with 7% cash fee and warrants.
- Expected close March 27, 2025; registration rights agreement requires filing by April 15, 2025.

## SEC filing metadata
- accession: 0000950170-25-044842
- form_type: 8-K
- ticker: JAGX
- cik: 0001585608
- company_name: Jaguar Health, Inc.
- filed_at: 2025-03-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1585608/000095017025044842/0000950170-25-044842-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1585608/000095017025044842/jagx-20250326.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-044842
- JSON: https://secwatch.observer/filing/0000950170-25-044842.json
- Plain text: https://secwatch.observer/filing/0000950170-25-044842.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.